Changes in the pathophysiologic profile of blood pressure determinants during short-term enalapril administration.

Abstract:

:To assess dose-related effects of enalapril, we treated eight hospitalized hypertensive patients receiving constant sodium intake with incremental doses of this new angiotensin converting-enzyme blocking drug. After a few days of placebo treatment, enalapril was given in single daily doses, starting with 1.25 mg and increasing dosage until blood pressure was adequately controlled. At the lowest dose, converting enzyme activity was reduced by 50%, but angiotensin II and blood pressure did not change significantly. There were, however, significant increases in norepinephrine, renin, and aldosterone. With higher doses there was a more pronounced reduction in converting enzyme activity, whereas angiotensin II, aldosterone, and blood pressure all fell significantly. Renin levels rose, but norepinephrine and epinephrine were reduced. In a second study 20 hypertensive subjects were studied before and after 10 days of continued treatment with enalapril. Again, systolic and diastolic pressure were significantly reduced. Tachycardia or orthostatic hypotension did not occur. Endocrine changes were similar to those after a single effective dose of enalapril. In addition, we found renal vasodilation and enhanced natriuresis together with a 1.2 kg decrement in body weight. Concurrently, plasma volume rose but renal blood flow remained unchanged. The data indicate that enalapril effectively lowers blood pressure, and it does so by converting enzyme inhibition; sodium loss and a decrease in sympathetic activity are associated features. Since plasma volume increased despite enhanced natriuresis, the drug may act both at the arteriolar and at the venular level.

journal_name

J Cardiovasc Pharmacol

authors

de Leeuw PW,Birkenhäger WH

doi

10.1097/00005344-198600081-00006

subject

Has Abstract

pub_date

1986-01-01 00:00:00

pages

S26-9

eissn

0160-2446

issn

1533-4023

journal_volume

8 Suppl 1

pub_type

杂志文章
  • Reduction in myocardial ischemic/reperfusion injury and neutrophil accumulation after therapeutic administration of streptokinase.

    abstract::The benefit of thrombolytic agents to reduce myocardial infarct size, improve left ventricular (LV) function, and prolong survival in human subjects is generally recognized, although the precise mechanism is poorly defined. This study was designed to evaluate the cardioprotective effects of streptokinase (SK) in rats,...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-199111000-00011

    authors: Smith EF 3rd,Nichols AJ,Sellers TS,O'Brien SR,Griswold DE,Egan JW,Hillegass LM,Vasko JA,Slivjak MJ,Davis PA

    更新日期:1991-11-01 00:00:00

  • Quantitative analysis of the interaction of [3H]spiroperidol with serotonin and dopamine receptors.

    abstract::Many radioligands used to study neurotransmitter receptors label multiple subtypes or multiple classes of receptors. Frequently, two subtypes or classes of receptors coexist in the same tissue and exhibit only slightly different affinities for a radioligand. A new analytical method has been developed to quantitate the...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:

    authors: McGonigle P

    更新日期:1988-01-01 00:00:00

  • Cardioprotective effects of NIP-121, a novel ATP-sensitive potassium channel opener, during ischemia and reperfusion in coronary perfused guinea pig myocardium.

    abstract::We investigated the effect of NIP-121, a novel ATP-sensitive K+ channel opener, on myocardial damage during ischemia/reperfusion. The action potential and contractile force of coronary-perfused guinea pig right ventricular walls were recorded. The preparations were subjected to 30-min no-flow ischemia with or without ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-199605000-00012

    authors: Tanaka H,Okazaki K,Shigenobu K

    更新日期:1996-05-01 00:00:00

  • Therapeutic considerations in applying rate control therapy for atrial fibrillation.

    abstract::The therapeutic strategy of heart rate control for atrial fibrillation (AF) is undergoing a renaissance since several recent randomized trials demonstrated clear advantages over the rhythm control for many patients. Heart rate control for AF is hampered, however, by a dearth of information relating target heart rates ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1097/FJC.0b013e31816d5f49

    authors: Wyse DG

    更新日期:2008-07-01 00:00:00

  • Prevention of postischemic myocardial reperfusion injury by the combined treatment of NCX-4016 and Tempol.

    abstract::Nitric oxide (NO) plays a protective role in myocardial ischemia-reperfusion (I/R) injury. However, the concomitant production of superoxide and other reactive oxygen species (ROS) during I/R may diminish the bioavailability of NO and hence compromise the beneficial effects. The objective of this study was to investig...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/01.fjc.0000242050.16790.65

    authors: Kutala VK,Khan M,Mandal R,Potaraju V,Colantuono G,Kumbala D,Kuppusamy P

    更新日期:2006-09-01 00:00:00

  • Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line.

    abstract::Endothelial cells and smooth muscle cells are the major cells that constitute blood vessels, and endothelial cells line the lumen of blood vessels. These 2 types of cells also play an integral role in the regional specialization of vascular structure. On the basis of these observations, we designed our study to invest...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/FJC.0b013e31803e8756

    authors: Bertrand-Thiebault C,Masson C,Siest G,Batt AM,Visvikis-Siest S

    更新日期:2007-05-01 00:00:00

  • [3H]bosentan binding to human coronary artery: functional correlates.

    abstract::The binding characteristics and localization of bosentan, an orally active endothelin-1 (ET-1) antagonist, were studied on sections of human coronary artery by in vitro autoradiography. Competition studies were performed to determine the ability of bosentan to prevent [125I]ET-1 binding to the coronary vasculature. Th...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Dashwood MR,Timm M,Muddle JR,Shah D,Tippins JR,Kaski JC

    更新日期:1995-01-01 00:00:00

  • Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death.

    abstract::Pinacidil is one of a number of new antihypertensive agents possessing an action that involves an enhanced potassium efflux in cardiac and vascular smooth muscle. An associated feature of pinacidil is a shortening of the cardiac action potential duration, which may constitute a potentially proarrhythmic effect. The pr...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-199003000-00016

    authors: Chi L,Uprichard AC,Lucchesi BR

    更新日期:1990-03-01 00:00:00

  • Metformin Exposure During Pregnancy and Lactation Did Not Cause Vascular Reactivity Alteration in Adult Male Offsprings.

    abstract::Metformin has been used for the treatment of some metabolic diseases during gestation and the beneficial effects of metformin to the vascular system have been described in diabetic and obese animal models. Nevertheless, the long-term consequences to the vascular system of offsprings maternally exposed to metformin hav...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/FJC.0000000000000520

    authors: Novi DRBS,Forcato S,Vidigal CB,Loiola GH,Gerardin DCC,Ceravolo GS

    更新日期:2017-11-01 00:00:00

  • Effects of nitrendipine and other calcium antagonists on glucose metabolism in man.

    abstract::Some calcium antagonists, including nitrendipine, were noted to cause a dose-dependent and reversible inhibition of insulin release in certain animal models. Therefore, it is important to know the effects of clinical treatment with calcium antagonists in nondiabetic or diabetic man. A review of the literature allows t...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章,评审

    doi:

    authors: Trost BN,Weidmann P

    更新日期:1984-01-01 00:00:00

  • Prostacyclin does not inhibit rho-kinase: an implication for the treatment of pulmonary hypertension.

    abstract::Primary pulmonary hypertension continues to be a fatal disease. We have recently demonstrated that long-term inhibition of Rho-kinase, an effector of the small GTPase Rho, is effective for the treatment of pulmonary hypertension (PH) in rats and humans. Prostacyclin has been clinically used for the treatment of PH wit...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/01.fjc.0000151898.65260.6a

    authors: Abe K,Morikawa K,Hizume T,Uwatoku T,Oi K,Seto M,Ikegaki I,Asano T,Kaibuchi K,Shimokawa H

    更新日期:2005-02-01 00:00:00

  • G protein-coupled receptor signaling in cardiac nuclear membranes.

    abstract::G protein-coupled receptors (GPCRs) play key physiological roles and represent a significant target for drug development. However, historically, drugs were developed with the understanding that GPCRs as a therapeutic target exist solely on cell surface membranes. More recently, GPCRs have been detected on intracellula...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1097/FJC.0000000000000196

    authors: Branco AF,Allen BG

    更新日期:2015-02-01 00:00:00

  • Nitric oxide in responses of regional kidney blood flow to vasoactive agents in anesthetized rabbits.

    abstract::To determine whether differential release of nitric oxide underlies the diversity of regional kidney blood flow responses to vasoactive agents, this study examined how nitric oxide synthase blockade with IV N(G)-nitro-L-arginine (L-NNA), and also IV L-NNA plus co-infusion of glyceryl trinitrate, affected responses to ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-200208000-00006

    authors: Rajapakse NW,Oliver JJ,Evans RG

    更新日期:2002-08-01 00:00:00

  • Pharmacologic and pharmacokinetic rationale for combination therapy in pulmonary arterial hypertension.

    abstract::Pulmonary arterial hypertension (PAH) is a progressive disease of the pulmonary vasculature characterized by elevated pulmonary artery pressure. Currently, there is no cure for this disease, and treatment is palliative. PAH therapies target 3 main pathways: prostacyclin, endothelin, and nitric oxide. The 3 distinct th...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1097/FJC.0b013e3181f89bdb

    authors: Gokhman R,Smithburger PL,Kane-Gill SL,Seybert AL

    更新日期:2010-12-01 00:00:00

  • Optimization of beta-blockers' pharmacology.

    abstract::Beta-adrenergic-blocking drugs (BABs) have a firm place in the therapy of cardiovascular conditions including angina and hypertension. Although all BABs are competitive inhibitors of beta-receptors, they may differ in their additional pharmacodynamics, i.e., beta1-(cardio)selectivity, partial agonistic activity (PAA),...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章,评审

    doi:

    authors: Tamargo J,Delpón E

    更新日期:1990-01-01 00:00:00

  • The effects of ACE inhibition on progression of atherosclerosis.

    abstract::Angiotensin-converting enzyme inhibitors have been extensively studied and established in the treatment of hypertension, heart failure, and ventricular dysfunction. They have various cardiac and vascular protective effects, but the relevant mechanisms of action in these areas remain to be fully understood. Possible ef...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章,评审

    doi:

    authors: Sharpe N

    更新日期:1993-01-01 00:00:00

  • Postexercise reflex control of forearm vascular resistance during calcium antagonism with slow-release oral isradipine.

    abstract::In untreated hypertensive patients, blood pressure is decreased during the hours that follow a single bout of exercise, but the mechanisms involved are as yet unknown. As antihypertensive chemotherapy may interfere with cardiovascular regulation, we investigated the effects of calcium antagonism with isradipine (slow-...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Cléroux J,Kouamé N,Yardley C,Marshall A,Lacourcière Y

    更新日期:1992-01-01 00:00:00

  • Treatment of transient myocardial ischemia in patients with stable angina: a comparative study of verapamil slow-release and nifedipine plus propranolol.

    abstract::We compared the effect of verapamil slow-release (VSR) and the combination of nifedipine plus propranolol on transient myocardial ischemia in a double-blind study comprising 20 patients with proven coronary artery disease and chronic stable angina. According to the results of 24-h Holter-monitoring recording, patients...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1097/00005344-199204000-00024

    authors: Molinero E,Salcedo A,Sagastagoitia JD,Arzubiaga J,Iriarte MM,Gómez Pajuelo C,Fernández Vidal P

    更新日期:1992-04-01 00:00:00

  • Effects of volatile anesthetics on ryanodine-treated ferret cardiac muscle.

    abstract::The volatile anesthetics halothane, isoflurane, and sevoflurane depress myocardial contractility by decreasing transsarcolemmal Ca2+ influx, Ca2+ release from the sarcoplasmic reticulum, Ca2+ sensitivity of the contractile proteins, and cross-bridge performance. The aim of this study is to assess and compare the effec...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-200108000-00006

    authors: Housmans PR,Bartunek AE

    更新日期:2001-08-01 00:00:00

  • Effects of hypercholesterolemia on the contractions to angiotensin II in the isolated aorta and iliac artery of the rabbit: role of arachidonic acid metabolites.

    abstract::The aim of this study was to investigate the effect of hypercholesterolemia on the angiotensin II-induced contractions in the isolated aorta and iliac artery of the rabbit, with respect to the role of arachidonate metabolites. Furthermore, the effect of the angiotensin-converting enzyme inhibitor ramipril was studied ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-199707000-00017

    authors: Dam JP,Vleeming W,Riezebos J,Post MJ,Porsius AJ,Wemer J

    更新日期:1997-07-01 00:00:00

  • Chronic nicotine exposure attenuates proangiogenic activity on human umbilical vein endothelial cells.

    abstract::The pathogenic mechanism of nicotine, a major product of smoking, on vascular endothelial cells is not well defined yet. The purpose of this study was to determine whether chronic exposure to nicotine alters angiogenic activity in human umbilical vein endothelial cells and to identify a potential role for endothelial ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/FJC.0b013e318206b5d9

    authors: Park HS,Cho K,Park YJ,Lee T

    更新日期:2011-03-01 00:00:00

  • Lack of oxidative stress during sustained therapy with isosorbide dinitrate and pentaerythrityl tetranitrate in healthy humans: a randomized, double-blind crossover study.

    abstract::The mechanisms by which tolerance to organic nitrates develops are still poorly understood. Enhanced oxidative stress, i.e., increased free radical production following organic nitrate administration, has been recently suggested as a possible mechanism. A randomized, double-blind, crossover study assessed in 18 health...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1097/00005344-200302000-00018

    authors: Keimer R,Stutzer FK,Tsikas D,Troost R,Gutzki FM,Frölich JC

    更新日期:2003-02-01 00:00:00

  • Plasma histamine and catecholamine levels during hypotension induced by morphine and compound 48/80.

    abstract::Histamine receptors are present in adrenergic terminals, and histamine is reported to inhibit release of the neurotransmitter norepinephrine (NE) at certain neuroeffector junctions. However, a physiological role for histamine in modifying adrenergic neurotransmission has not been established. To examine the interactio...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-198705000-00012

    authors: Muldoon SM,Freas W,Mahla ME,Donlon MA

    更新日期:1987-05-01 00:00:00

  • Hemodynamic responses to sarafotoxin 6 peptides.

    abstract::Hemodynamic responses to sarafotoxin (SFTX6) peptides and endothelin-1 (ET-1) were compared in the anesthetized cat. SFTX6a and ET-1 at a dose of 0.3 nmol/kg i.v. produced a biphasic change in arterial pressure characterized by an initial decrease followed by a secondary increase in pressure. In contrast, similar dose...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-199100177-00083

    authors: Minkes RK,Kadowitz PJ

    更新日期:1991-01-01 00:00:00

  • Association between statin therapy and tendon rupture: a case-control study.

    abstract::Although case reports of a possible association between statin therapy and tendon rupture have been published, no analytical studies exploring this relationship have been reported. We conducted a case-control study using the electronic medical records at Michigan State University from 2002 to 2007 to assess whether st...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/FJC.0b013e3181a0ce8b

    authors: Beri A,Dwamena FC,Dwamena BA

    更新日期:2009-05-01 00:00:00

  • Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine.

    abstract::This study was performed to determine if cardiodepression can be dissociated from cardioprotection with calcium antagonists and which one (diltiazem, nifedipine, or verapamil) can maximally protect ischemic myocardium at a given level of cardiodepression. Isolated rat hearts were subjected to 0.1, 0.5, or 1.0 microM d...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Grover GJ,Sleph PG

    更新日期:1989-08-01 00:00:00

  • Characterization of endothelin-1 stimulation of catecholamine release from adrenal chromaffin cells.

    abstract::Addition of endothelin-1 (ET-1) to primary cultures of bovine adrenal chromaffin cells causes a significant enhancement of norepinephrine and epinephrine efflux, with an EC50 of about 1 nM. A maximally effective concentration of endothelin (10 nM) gives a transient increase in noradrenaline release within 5 min. The a...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-198900135-00066

    authors: Boarder MR,Marriott DB

    更新日期:1989-01-01 00:00:00

  • Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities.

    abstract::A number of studies using endothelin (ET) precursors, commonly termed big ETs, have revealed the presence of endothelin-converting enzyme (ECE) activity in various vascular and nonvascular preparations. Since then, more than one ECE has been cloned. It has also been observed that big ET-1 and big ET-3 are not converte...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-199800001-00019

    authors: Rizzi A,Calo G,Battistini B,Regoli D

    更新日期:1998-01-01 00:00:00

  • Effects of oral carbocromene pretreatment on infarct size following experimental coronary artery occlusion.

    abstract::This study examines the acute effects of the antianginal drug carbocromene (chromonar) in dogs (20 mg/kg p.o., twice daily for 8 weeks) on mortality, hemodynamics, coronary collateral blood flow, and myocardial infarct size. Following the chronic pretreatment and during acute phase of the experiments, the animals rece...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-198201000-00004

    authors: Fiedler VB,Nitz RE,Buchheim S

    更新日期:1982-01-01 00:00:00

  • Low-density lipoprotein inhibits receptor-mediated prostaglandin synthesis without affecting calcium and arachidonic acid mobilization in human endothelial cells.

    abstract::Vascular serotonin 5-HT1 receptors have quiescent constrictor activity that is activated by other vasoactive agents such as histamine. Previously, we observed that the 5-HT1-selective agonist 5-carboxamidotryptamine (5-CT) potentiated histamine-stimulated arachidonic acid (AA) mobilization and prostaglandin production...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-200411000-00015

    authors: Kilbourne EJ

    更新日期:2004-11-01 00:00:00